Skip to main content
v2026.11,986 entries · CC-BY 4.0

Editorial · CASRAI · Clinical research and clinical trials

Africa CDC and Canada sign pact on laboratory systems and research

Africa CDC and Canada signed a framework for cooperation on laboratories, surveillance and research, with African-led science among its goals.

Published 17 Nov 2026· 5 minute read

Ask CASRAI · free to try

Ask about this story

2 free questions a day, no account.

An AI assistant for research: funder rules, compliance, methods and publishing. It links the sources behind its answers and labels answers that come from a web search.

Answers draw on CASRAI's guides and dictionary plus the federal and funder documents we index: Federal Register, Grants.gov, Regulations.gov and UKRI.

Works on this site and inside Claude, Cursor and the AI tools you already use.

Everything CASRAI publishes — this page, the dictionary, the guides and the news — stays open to read, with no account and no card.

CASRAI is the reference for research administration — bookmark it for the next question.

Africa CDC and the Public Health Agency of Canada signed a memorandum on laboratory systems, disease surveillance and research in Addis Ababa on 15 November 2026, according to Africa CDC’s announcement carried by AllAfrica. Published on 16 November, the agreement announcement sets out a framework for cross-border scientific cooperation and stronger African public health institutions.

Five priorities for scientific cooperation

The Africa CDC notice names Director General Jean Kaseya and Public Health Agency of Canada president Nancy Hamzawi as the signatories. Their agencies will pursue technical cooperation, knowledge exchange and joint initiatives across five areas:

  • Epidemiological surveillance and public health intelligence.
  • Laboratory systems, including biosafety and biosecurity.
  • Public health emergency preparedness and response.
  • Development of the public health workforce.
  • Research, innovation and medical countermeasures.

Africa CDC links the partnership to African-led research, more equitable access to medical countermeasures and local manufacturing. These aims sit within the African Union’s Africa Health Security and Sovereignty agenda, which emphasises stronger institutions and less dependence on external support during emergencies.

Canadian response funding follows separate tracks

Canada’s 28 May announcement committed C$8 million in international assistance for the Ebola response. It allocated C$2 million to Africa CDC for surveillance and biosecurity, C$3.5 million to the World Health Organization’s Contingency Fund for Emergencies and C$1.8 million to the Canadian Red Cross. Two further allocations of C$350,000 each supported Oxfam-Quebec and World Vision Canada through the Canadian Humanitarian Assistance Fund.

Global Affairs Canada also described an existing relationship with Africa CDC through its Weapons Threat Reduction Program and the Canada-led Signature Initiative to Mitigate Biological Threats in Africa. The November memorandum therefore builds on an established institutional relationship. The May figures describe that earlier response commitment; they are not a newly announced budget for the memorandum.

On 16 November, Prime Minister Mark Carney welcomed the MoU at the Francophonie summit in Phnom Penh, Cambodia. He also announced C$24 million for projects across Francophone Africa, including C$2 million for Ebola preparedness and response.

The accompanying Canadian funding backgrounder identifies UNICEF as the partner for that C$2 million, over two years, in the Democratic Republic of Congo, Uganda and other African countries at risk. Its activities include community engagement, infection prevention, water and sanitation, and procurement and distribution of protective equipment and medical supplies. This allocation is a distinct response project alongside the agency cooperation framework.

Africa CDC is expanding its institutional partnerships

The Canadian agreement follows another formal partnership announced earlier this year. On 9 March, the European Centre for Disease Prevention and Control and Africa CDC signed their first MoU, covering surveillance, risk assessment, emergency preparedness and response.

ECDC said that agreement also supports data analytics, modelling, laboratory capabilities, workforce development and public health training. It described a decade of cooperation between the agencies and called Africa CDC its first supranational disease-control-agency MoU partner. These overlapping subjects show the institutional setting for the Canadian pact: laboratory science and research capacity are being organised through relationships between public health agencies, alongside individual outbreak-response projects.

Kaseya stresses shared health security

Kaseya described African and global health security as interconnected and pointed to laboratories, epidemiological intelligence and a trained workforce as essential capabilities. He presented the Canadian relationship as mutually beneficial cooperation. In its 16 November statement, Canada likewise identified testing capabilities, research and medical countermeasures among the memorandum’s objectives.

TechTimes’ 16 November reporting also centred on the surveillance, laboratory and countermeasure priorities, connecting the agreement to Canada’s existing scientific capabilities and earlier cooperation with Africa CDC. That institutional focus matters for research organisations assessing where their expertise could fit.

What the framework means for research offices

For universities and public laboratories, the relevant development is a channel for agency-level scientific cooperation. The five priorities give prospective partners a way to locate their work: surveillance and analytical teams align with public health intelligence; laboratory groups with testing systems and biosecurity; training organisations with workforce development; and research teams with innovation and countermeasures.

The practical distinction is between this broad framework and the terms of a particular collaboration. A research collaboration agreement addresses the work institutions actually undertake. Research offices considering participation should identify the responsible agency and the specific initiative before planning a university project or treating an announcement as an application opportunity.

Similarly, a surveillance priority should guide discussion of the information a joint initiative would need. A project-specific data sharing agreement remains a separate matter from an institutional statement of cooperation. The memorandum’s priorities should not be read as an automatic data licence or laboratory-access entitlement.

Africa CDC’s emphasis on African-led science also provides a concrete basis for evaluating prospective partnerships: who sets the research agenda, which institutions develop lasting capabilities and how a collaboration supports local scientific leadership. For research administrators, those questions connect the announced health-sovereignty objective to the design of future joint work.

Sources

Referenced across the research world

University of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logoUniversity of Cambridge logoColumbia University logoCrossref logoUniversity of Edinburgh logoHarvard University logoUniversity of Oxford logoPrinceton University logoStanford School of Medicine logoUniversity College London logoORCID logo
  • University of Cambridge logo
  • Columbia University logo
  • Crossref logo
  • University of Edinburgh logo
  • Harvard University logo
  • University of Oxford logo
  • Princeton University logo
  • Stanford School of Medicine logo
  • University College London logo
  • ORCID logo

View CASRAI adoption →